Brief: Annexin Pharmaceuticals Resolves On SEK 50 Million Rights Issue
Feb 6 (Reuters) - Annexin Pharmaceuticals AB (publ)
ANNX.ST :
* RESOLVES ON SEK 50 MILLION RIGHTS ISSUE
* SUBSCRIPTION PRICE IN RIGHTS ISSUE SET AT SEK 0.30 PER NEW
SHARE
* SUBSCRIPTION PERIOD FOR RIGHTS ISSUE FROM MARCH 7 TO MARCH
24,
2025
Source text: ID:nMFN1KwmF3
Further company coverage: ANNX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Annexin Pharmaceuticals AB (publ)
See all newsBrief: Annexin Pharmaceuticals Q3 Net Loss At SEK 9.5 Mln
Brief: Annexin Pharmaceuticals Q2 2026 Net Loss SEK 11.6 Mln
Brief: Annexin Pharmaceuticals Gets International Nonproprietary Name Drug Candidate Anxv
Brief: Annexin Pharmaceuticals Updates On Nine Patients Treated In Nexus Study
Brief: Annexin's Rights Issue 98% Subscribed